During the past years, there has been a global outbreak of allergic diseases, presenting a
considerable medical and socioeconomical burden. A large fraction of allergic diseases is …

Modern health care requires a proactive and individualized response to diseases,
combining precision diagnosis and personalized treatment. Accordingly, the approach to …

The exponential growth of precision diagnostic tools, including omic technologies, molecular
diagnostics, sophisticated genetic and epigenetic editing, imaging and nano‐technologies …

In drug hypersensitivity, drug provocation testing (DPT), also called drug challenge, is the
gold standard for investigation. In recent years, risk stratification has become an important …

Nonsteroidal anti‐inflammatory drugs (NSAIDs), the medications most commonly used for
treating pain and inflammation, are the main triggers of drug hypersensitivity reactions. The …

Drug hypersensitivity reactions induced by small molecule drugs encompass a broad
spectrum of adverse drug reactions with heterogeneous clinical presentations and …

Immediate drug hypersensitivity reactions (IDHRs) are a burden for patients and the health
systems. This problem increases when taking into account that only a small proportion of …

Abstract The European Academy of Allergy and Clinical Immunology (EAACI) organized the
first European Strategic Forum on Allergic Diseases and Asthma. The main aim was to bring …

A correct diagnosis of drug hypersensitivity reactions (DHRs) is very important for both the
patient and health system. However, DHRs diagnosis is complex, time consuming, requires …

Drug-induced anaphylaxis in children is less common than in adults and primarily involves
beta-lactams and nonsteroidal anti-inflammatory drugs. Epidemiological studies show …